Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Shareholders' Equity (Unaudited)

v3.21.1
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Preferred Stock [Member]
Additional Paid In Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2019 $ 46,125 $ 6,513,396 $ 138,024,957 $ (127,352,826) $ 17,231,652
Balance, shares at Dec. 31, 2019 46,124,803 16,017,113.941      
Compensation expense relating to option issuances 865,110 865,110
Series C dividend $ 661,458 (661,458)
Series C dividend, shares   19.542      
Net loss (5,187,760) (5,187,760)
Balance at Mar. 31, 2020 $ 46,125 $ 7,174,854 138,890,067 (133,202,044) 12,909,002
Balance, shares at Mar. 31, 2020 46,124,803 16,017,133.483      
Balance at Dec. 31, 2020 $ 91,767 $ 7,174,854 164,022,957 (154,444,983) 16,844,595
Balance, shares at Dec. 31, 2020 91,766,928 16,017,133.483      
Compensation expense relating to option issuances     1,123,761 1,123,761
Issuance of common stock from warrant exercise $ 2,472 2,258,864   2,261,336
Issuance of common stock from warrant exercise, shares 2,472,573        
Series C dividend $ 1,117,531 (1,117,531)
Series C dividend, shares 33.016      
Series C redemption $ (5,635,672) 5,635,672
Series C redemption, shares (166.499)      
ATM offering - net of expenses $ 21,399 26,654,993 26,676,392
ATM offering - net of expenses, shares 21,398,765        
Net loss (5,219,945) (5,219,945)
Balance at Mar. 31, 2021 $ 115,638 $ 2,656,713 $ 194,060,575 $ (160,782,459) $ 36,050,467
Balance, shares at Mar. 31, 2021 115,638,266 16,017,000.000